Bank of Montreal’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bank of Montreal’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-160	Closed	–	–	5533
2021 Q1	$0	Hold	160	–	–	﹤0.01%	5523
2020 Q4	$0	Hold	160	–	–	﹤0.01%	5260
2020 Q3	$0	Buy	+160	New	+$574	﹤0.01%	5047
2016 Q2	–	Sell	-43	Closed	-$1K	–	4442
2016 Q1	$1K	Hold	43	–	–	﹤0.01%	4131
2015 Q4	$1K	Buy	43 +42	+4,200%	+$1.46K	﹤0.01%	4150
2015 Q3	$0	Hold	1	–	–	﹤0.01%	4250
2015 Q2	$0	Sell	1 -130	-99%	-$3.78K	﹤0.01%	4209
2015 Q1	$4K	Hold	131	–	–	﹤0.01%	3685
2014 Q4	$5K	Sell	131 -22	-14%	-$605	﹤0.01%	3715
2014 Q3	$4K	Hold	153	–	–	﹤0.01%	3842
2014 Q2	$5K	Buy	+153	New	+$4.95K	﹤0.01%	4204

Other funds holding NAVB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's NAVB Position: Q2 2021 in Review

Bank of Montreal sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2021, closing a stake of 160 shares.

Bank of Montreal first reported a position in NAVB in Q2 2014 and held it in 11 quarters. The position peaked at $5K in Q4 2014. 31 funds tracked by Wall St. Rank hold NAVB as of Q2 2021.

Bank of Montreal reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 160 Navidea Biopharmaceuticals Inc. shares in Q2 2021.
Bank of Montreal first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2014 and held it in 11 quarters.
Bank of Montreal's Navidea Biopharmaceuticals Inc. position peaked at $5K in Q4 2014.
31 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.